These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 21070434

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical experience with the MammoSite radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial.
    Niehoff P, Polgár C, Ostertag H, Major T, Sulyok Z, Kimmig B, Kovács G.
    Radiother Oncol; 2006 Jun; 79(3):316-20. PubMed ID: 16780977
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience.
    Harper JL, Jenrette JM, Vanek KN, Aguero EG, Gillanders WE.
    Int J Radiat Oncol Biol Phys; 2005 Jan 01; 61(1):169-74. PubMed ID: 15629608
    [Abstract] [Full Text] [Related]

  • 8. Phase I/II study evaluating early tolerance in breast cancer patients undergoing accelerated partial breast irradiation treated with the mammosite balloon breast brachytherapy catheter using a 2-day dose schedule.
    Wallace M, Martinez A, Mitchell C, Chen PY, Ghilezan M, Benitez P, Brown E, Vicini F.
    Int J Radiat Oncol Biol Phys; 2010 Jun 01; 77(2):531-6. PubMed ID: 19775830
    [Abstract] [Full Text] [Related]

  • 9. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
    Trombetta M, Julian TB, Werts DE, McWilliams W, Kim Y, Miften M, Parda D.
    Am J Clin Oncol; 2009 Jun 01; 32(3):314-8. PubMed ID: 19451803
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Early European experience with the MammoSite radiation therapy system for partial breast brachytherapy following breast conservation operation in low-risk breast cancer.
    Niehoff P, Ballardini B, Polgár C, Major T, Hammer J, Richetti A, Kovács G.
    Breast; 2006 Jun 01; 15(3):319-25. PubMed ID: 16765284
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer.
    Richards GM, Berson AM, Rescigno J, Sanghavi S, Siegel B, Axelrod D, Bernik S, Scarpinato V, Mills C.
    Ann Surg Oncol; 2004 Aug 01; 11(8):739-46. PubMed ID: 15249336
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer.
    Perera F, Chisela F, Stitt L, Engel J, Venkatesan V.
    Int J Radiat Oncol Biol Phys; 2005 Aug 01; 62(5):1283-90. PubMed ID: 16029783
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.